J. Blouin

发表

CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations

G. Cullot, J. Boutin, J. Toutain, 2019, Nature Communications.

Spleen route accelerates engraftment of human hematopoietic stem cells.

J. Boutin, I. Lamrissi‐Garcia, J. Blouin, 2021, Biochemical and biophysical research communications.

Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy

C. Ged, J. Blouin, E. Richard, 2021, Molecular genetics and metabolism reports.

Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria

P. Dubus, J. Castilla, J. Oyarzábal, 2018, Science Translational Medicine.

High-protein diet differently modifies intestinal goblet cell characteristics and mucosal cytokine expression in ileum and colon.

Annaïg Lan, J. Blouin, D. Tomé, 2015, The Journal of nutritional biochemistry.

Pyruvate Dehydrogenase Kinase 4

J. Blouin, F. Fouque, E. Distel, 2008, Diabetes.

Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.

I. Lamrissi‐Garcia, M. Lalanne, C. Ged, 2020, Blood.

Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria

M. Lalanne, C. Ged, J. Blouin, 2013, Proceedings of the National Academy of Sciences.

Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria).

I. Lamrissi‐Garcia, M. Lalanne, C. Ged, 2019, Biochemical and biophysical research communications.

An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid

J. Boutin, M. Lalanne, J. Blouin, 2022, Cancers.

Detoxification of H(2)S by differentiated colonic epithelial cells: implication of the sulfide oxidizing unit and of the cell respiratory capacity.

J. Blouin, R. Benamouzig, C. Chaumontet, 2012, Antioxidants & redox signaling.

Natural and pharmacological chaperones against accelerated protein degradation: uroporphyrinogen III synthase and congenital erythropoietic porphyria

J. Blouin, E. Richard, O. Millet, 2020 .

Lactose malabsorption and colonic fermentations alter host metabolism in rats

J. Blouin, R. Benamouzig, P. Even, 2013, British Journal of Nutrition.

Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1.

P. Dubus, M. Lalanne, J. Blouin, 2019, Stem cell research.

Late diagnosis of primary hyperoxaluria type III

J. Blouin, J. Harambat, R. de La Faille, 2017, Annals of clinical biochemistry.

Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition

M. Lalanne, C. Ged, J. Blouin, 2017, Human molecular genetics.

Mutation-Specific Guide RNA for Compound Heterozygous Porphyria On-target Scarless Correction by CRISPR/Cas9 in Stem Cells

G. Cullot, J. Boutin, J. Toutain, 2020, Stem cell reports.

Acute and selective regulation of glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase in adipose tissue by thiazolidinediones in type 2 diabetes

F. Karpe, J. Blouin, H. Vidal, 2007, Diabetologia.

Butyrate elicits a metabolic switch in human colon cancer cells by targeting the pyruvate dehydrogenase complex

X. Coumoul, P. Laurent-Puig, R. Barouki, 2011, International journal of cancer.

CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells

D. Cappellen, G. Cullot, J. Boutin, 2021, Nature Communications.

Phlebotomy as an efficient long-term treatment of congenital erythropoietic porphyria.

C. Ged, J. Blouin, E. Richard, 2020, Haematologica.

Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology.

P. Dubus, M. Lalanne, J. Blouin, 2019, Biochemical and biophysical research communications.

PDK 4 in adipocyte glyceroneogenesis Pyruvate dehydrogenase kinase 4 : regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue

J. Blouin, F. Fouque, E. Distel, 2008 .

High-protein diet modifies colonic microbiota and luminal environment but not colonocyte metabolism in the rat model: the increased luminal bulk connection.

Annaïg Lan, J. Blouin, D. Tomé, 2014, American journal of physiology. Gastrointestinal and liver physiology.

Recurrent posterior reversible encephalopathy syndrome in a patient with acute intermittent porphyria.

C. Ged, J. Blouin, E. Richard, 2019, Revue neurologique.

Detrimental effects for colonocytes of an increased exposure to luminal hydrogen sulfide: The adaptive response.

Annaïg Lan, J. Blouin, R. Benamouzig, 2016, Free radical biology & medicine.

Down-regulation of the phosphoenolpyruvate carboxykinase gene in human colon tumors and induction by omega-3 fatty acids.

P. Laurent-Puig, J. Blouin, G. Penot, 2010, Biochimie.